BioBridge Global (EIN 454765222) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2012

Legal Domicile

Phone

2107579505

Tax Period

2024-01-01 to 2024-12-31

BioBridge Global, founded in 2012, is a mid-sized nonprofit in the Health Care sector that reported $45.3M in total revenue in fiscal year 2024. Revenue grew 12% year-over-year, indicating healthy expansion. Expenses of $43.2M left a modest 5% surplus.

Mission

BIOBRIDGE GLOBAL (BBG) IS ORGANIZED FOR THE EXCLUSIVE PURPOSE OF SUPPORTING, AS THE SOLE MEMBER, SOUTH TEXAS BLOOD & TISSUE CENTER (CONTINUED ON SCHEDULE O)

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $310,591

Program Service Revenue $42,667,224

Investment Income $2,204,746

Other Revenue $150,034

TOTAL REVENUE $45,332,595

Expense Breakdown

Grants Paid $460,900

Salaries & Benefits $31,877,933

Fundraising Expenses $0

Program Expenses $43,230,038

Other Expenses $10,891,205

TOTAL EXPENSES $43,230,038

Year-over-Year Comparison

	2024	2023	Change
Revenue	$45,332,595	$40,649,086	+0.1%
Expenses	$43,230,038	$39,281,452	+0.1%
Net Income	$2,102,557	$1,367,634	+0.5%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

228

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$4,246,816

Total Directors

$1,133,783

Key Employees

$677,488

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
GABRIELE NIEDERAUER PHD	CHAIR	1.0	Officer Director	$0	$0	$0
JAMES ROSENBLATT JD	SECRETARY	1.0	Officer Director	$0	$0	$0
JEANNIE FRAZIER	TREASURER	1.0	Officer Director	$0	$0	$0
MARTIN J LANDON	EX-OFFICIO DIR/CEO	49.0	Officer Director	$1,088,471	$45,312	$1,133,783
MICHAEL KREAGER JD	CHAIR EMERITUS/ASST SECRETARY	1.0	Officer Director	$0	$0	$0
RANDI BROSTERMAN HUTCHENS	VICE-CHAIR	1.0	Officer Director	$0	$0	$0
STEVEN BROOK JD	IMMEDIATE PAST CHAIR	1.0	Officer Director	$0	$0	$0
AL RAJWANI	DIRECTOR	1.0	Director	$0	$0	$0
BARBARA R HOLCOMB RN BSN MSN	DIRECTOR	1.0	Director	$0	$0	$0
CHARLES J LERNER MD FSHEA FACP	DIRECTOR	1.0	Director	$0	$0	$0
DONALD H JENKINS MD FACS	DIRECTOR	1.0	Director	$0	$0	$0
J CHARLENE DAVIS PHD	DIRECTOR	1.0	Director	$0	$0	$0
JENNA SAUCEDO-HERRERA	DIRECTOR	1.0	Director	$0	$0	$0
JOHN FEIK	DIRECTOR EMERITUS	1.0	Director	$0	$0	$0
KENNETH GINDY JD	DIRECTOR EMERITUS	1.0	Director	$0	$0	$0
KENNETH P TREVETT JD	DIRECTOR EMERITUS	1.0	Director	$0	$0	$0
THOMAS M MCNISH MD MPH	DIRECTOR EMERITUS	1.0	Director	$0	$0	$0
ADRIENNE MENDOZA	SVP, COO STBTC	1.0	Officer	$0	$28,544	$423,265
GRANVILLE BETTON	SVP, TALENT AND PERFORMANCE MGMT	50.0	Officer	$295,970	$48,440	$344,410
JOHN WILLIAM YOUNGDAHL	SVP/CFO	50.0	Officer	$383,663	$37,134	$420,797
MARK EDWARD FITE	SVP, COO, QUALTEX	1.0	Officer	$0	$40,003	$476,889
RACHEL-LOUISE BEDDARD	SVP/CHIEF MEDICAL OFFICER	50.0	Officer	$427,724	$55,678	$483,402
THOMAS SCOTT JONES	SVP, CHIEF SCIENTIFIC OFFICER	50.0	Officer	$357,318	$45,581	$402,899
WILLIAM RICHEY WYATT	SVP/GEN COUNSEL & CHIEF COMPLIANCE OFFICER	50.0	Officer	$505,643	$55,728	$561,371
CHRISTOPHER JOHNSON	VP, SUPPLY CHAIN & SUPPORT SERVICES	50.0	Key Emp	$261,470	$49,630	$311,100
JOSE MURILLO	VP. INFORMATION TECHNOLOGY	50.0	Key Emp	$311,641	$54,747	$366,388
ANAND SRINIVASAN	VP, TECHNOLOGY & INNOVATIONS	50.0	Highest	$324,473	$15,803	$340,276
Benjamin Lopez	Sr. Director, Finance & Accounting	50.0	Highest	$229,935	$22,583	$252,518
CHRISTIE MALONE	SR. DIRECTOR, CUSTOM SOLUTIONS & SALES SUP	25.0	Highest	$232,978	$30,546	$263,524
EMMANUEL CASASOLA	EXECUTIVE DIRECTOR, GLOBAL QUALITY	50.0	Highest	$237,123	$28,301	$265,424
SOPHIE BARDY	VP MARKETING	50.0	Highest	$298,853	$56,361	$355,214

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$45,332,595	$43,230,038	$83,238,285	$2,102,557
2023	$40,649,086	$39,281,452	$75,173,327	$1,367,634
2022	$36,640,731	$34,844,828	$69,766,084	$1,795,903
2021	$35,430,455	$31,920,674	$72,557,364	$3,509,781
2020	$30,301,028	$30,935,950	$70,894,449	$-634,922
2019	$27,210,328	$27,068,715	$65,163,575	$141,613
2018	$29,878,904	$22,541,414	$58,953,278	$7,337,490

BioBridge Global